Clinical Trials Browser

Interventional × Thalassemia × fludarabine × Clear all

NCT05736419 2026-03-05

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Phase 2 Recruiting

Classical hematology

Anemia, Sickle Cell, Thalassemia, beta-Thalassemia

NCT00578292 2020-05-01

THALLO

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia